Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Recognizing trichofolliculomas is important to avoid unnecessary surgery.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

TQC shows promise for better hair regrowth in treating hair loss.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

A girl with a rare skin condition improved after one month of treatment with acitretin.

The dual-wavelength laser system effectively reduces EFFC symptoms with minimal side effects.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

There are various treatment options for frontal fibrosing alopecia.

Olorofim effectively treats fungal skin infections.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

KF19418 promotes hair growth similarly to minoxidil but is not better in live mice.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.